Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) — Free Cash Flow Generation Index
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) has a Free Cash Flow Generation Index of 0.67x as of December 2025. Free cash flow of $87.15 Million represents 1% of operating cash flow ($130.31 Million). Read Amneal Pharmaceuticals, Inc. Class A Com total liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Amneal Pharmaceuticals, Inc. Class A Common Stock Free Cash Flow Generation Index (2014–2025)
Historical FCF Generation Index trend for Amneal Pharmaceuticals, Inc. Class A Common Stock across 12 annual periods. Explore AMRX capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Amneal Pharmaceuticals, Inc. Class A Common Stock (2014–2025)
Year-by-year Free Cash Flow Generation Index for Amneal Pharmaceuticals, Inc. Class A Common Stock. For the full company profile including market capitalisation, see AMRX company net worth.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.79x | $269.93 Million | $339.99 Million | $70.06 Million | ▲ +6.4% |
| 2024 | 0.75x | $220.11 Million | $295.10 Million | $74.99 Million | ▼ -6.7% |
| 2023 | 0.80x | $276.39 Million | $345.58 Million | $69.19 Million | ▲ +304.2% |
| 2022 | -0.39x | $-25.50 Million | $65.10 Million | $90.59 Million | ▼ -148.8% |
| 2021 | 0.80x | $194.09 Million | $241.82 Million | $47.73 Million | ▼ -4.1% |
| 2020 | 0.84x | $317.16 Million | $379.00 Million | $61.84 Million | ▲ +101.5% |
| 2019 | -56.14x | $-95.73 Million | $1.71 Million | $97.43 Million | ▼ -9273.8% |
| 2018 | 0.61x | $153.14 Million | $250.23 Million | $97.09 Million | ▲ +19.5% |
| 2017 | 0.51x | $119.92 Million | $234.19 Million | $114.27 Million | ▲ +717.2% |
| 2016 | -0.08x | $-9.55 Million | $115.06 Million | $124.61 Million | ▲ +30.4% |
| 2015 | -0.12x | $-12.50 Million | $104.88 Million | $117.38 Million | ▼ -140.7% |
| 2014 | 0.29x | $32.87 Million | $112.26 Million | $79.38 Million | — |